Related Experiment Video

Updated: Jun 1, 2026

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice
07:25

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice

Published on: September 25, 2019

Hot topic in hepatitis C virus research: the type of immunosuppression does not matter

Marina Berenguer1

  • 1Hepatology Unit, La Fe Hospital, Valencia, Spain. mbhaym@teleline.es

Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society
|June 3, 2011
PubMed

Insights

Recurrent hepatitis C virus (HCV) progression after liver transplant varies. Immunosuppression impacts disease, but donor age and specific agents are less critical than avoiding steroid boluses and utilizing antiviral therapy for better outcomes.

Area of Science:

  • Hepatology
  • Transplant Immunology
  • Virology

Background:

  • Recurrent hepatitis C virus (HCV) infection post-liver transplantation presents a significant clinical challenge.
  • The natural history and factors influencing HCV recurrence and progression remain incompletely understood.
  • Optimizing management strategies is crucial for improving long-term outcomes in liver transplant recipients.

Purpose of the Study:

  • To elucidate the key determinants of disease progression in recurrent hepatitis C virus (HCV) infection after liver transplantation.
  • To evaluate the impact of donor age, immunosuppressive regimens, and antiviral therapy on HCV recurrence and outcomes.
  • To provide evidence-based recommendations for managing immunosuppression and antiviral treatment in this patient population.

Main Methods:

  • Retrospective analysis of liver transplant recipients with recurrent HCV.
  • Assessment of donor age, type and duration of immunosuppressive agents, and use of antiviral therapy.
  • Correlation of clinical variables with virologic control, fibrosis progression, and patient survival.

Main Results:

  • The natural history of recurrent HCV is highly variable, with old donor age being a consistent factor influencing disease progression.
  • Overall immunosuppression levels, rather than specific agents, dictate HCV-related disease progression.
  • Steroid boluses were associated with increased viremia, accelerated fibrosis, and reduced survival.
  • Successful antiviral therapy correlated with improved outcomes in liver transplant recipients with HCV.

Conclusions:

  • Donor age and overall immunosuppression are critical factors in recurrent HCV progression; specific immunosuppressive agents are less influential.
  • Steroid boluses should be avoided due to adverse effects on viremia, fibrosis, and survival.
  • Antiviral therapy is associated with improved outcomes, and modifying immunosuppression before initiating antivirals is not supported by current data.
Abstract

More Related Videos

Two Methods of Heterokaryon Formation to Discover HCV Restriction Factors16:49

Two Methods of Heterokaryon Formation to Discover HCV Restriction Factors

Published on: July 16, 2012

Establishment of the Dual Humanized TK-NOG Mouse Model for HIV-associated Liver Pathogenesis10:12

Establishment of the Dual Humanized TK-NOG Mouse Model for HIV-associated Liver Pathogenesis

Published on: September 11, 2019

Related Concept Videos

Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
Retrovirus Life Cycles01:10

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Immunodeficiency Diseases01:25

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency disorders...
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...